Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;100(5):e13407.
doi: 10.1111/sji.13407. Epub 2024 Sep 16.

No signs of mast cell involvement in long-COVID: A case-control study

Ole Bernt Lenning  1 , Grete Jonsson  2 , Tore Grimstad  3   4 , Emiel A M Janssen  5   6 , Geir Sverre Braut  1   7 , Frode Berven  8 , Roald Omdal  1   4
Affiliations

No signs of mast cell involvement in long-COVID: A case-control study

Ole Bernt Lenning et al. Scand J Immunol. 2024 Nov.

Abstract

Long-COVID caused by SARS-CoV-2 infection has significant and increasing effects on human health worldwide. Although a unifying molecular or biological explanation is lacking, several pathophysiological mechanisms have been proposed. Involvement of mast cells-evolutionary old "multipurpose" innate immune cells-was reported recently in studies of acute infection and post-acute-COVID-19 syndrome. Mast cell activity has been suggested in long-COVID. In this case-control study, we compared data from 24 individuals with long-COVID (according to the NICE criteria) and 24 age- and sex-matched healthy individuals with a history of SARS-CoV-2 infection without developing sequelae. Serum levels of the proteases beta-tryptase (TPSB2) and carboxypeptidase (CPA3), which are mast cell specific, were measured using immunoassays. The values were compared between the two groups and correlated to measures of physical exertional intolerance. TPSB2 and CPA3 levels were median (range) 26.9 (2.0-1000) and 5.8 (1.5-14.0) ng/mL, respectively, in the long-COVID group. The corresponding values in the control group were 10.9 (2.0-1000) (p = 0.93) and 5.3 (3.5-12.9) ng/mL (p = 0.82). No significant correlations between TPSB2 or CPA3 levels and scores on the ten physical subscales of SF-36, 3.1-3.10 were revealed. We found no significant differences in the levels of mast cell activation markers TPSB2 and CPA3 between the long-COVID and control groups and no correlations with proxy markers of exercise intolerance. Mast cell activation does not appear to be part of long-term pathogenesis of long-COVID, at least in the majority of patients.

Keywords: exertional intolerance; long‐COVID; mast cells; mast cell‐derived proteases.

PubMed Disclaimer

References

REFERENCES

    1. Altmann DM, Whettlock EM, Liu S, Arachchillage DJ, Boyton RJ. The immunology of long COVID. Nat Rev Immunol. 2023;23(10):618‐634.
    1. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133‐146.
    1. FAIR Health. Patients diagnosed with post‐COVID conditions: an analysis of private healthcare claims using the official ICD‐10 diagnostic code (FAIR Health, 2022). Patients Diagnosed with Post‐COVID Conditions ‐ A FAIR Health White Paper.pdf. Published May 18, 2022. Accessed January 31, 2022.
    1. Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long‐COVID and its underlying pathophysiological mechanism. Infection. 2022;50(5):1053‐1066.
    1. Dahlin JS, Maurer M, Metcalfe DD, Pejler G, Sagi‐Eisenberg R, Nilsson G. The ingenious mast cell: contemporary insights into mast cell behavior and function. Allergy. 2022;77(1):83‐99.

LinkOut - more resources